<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04012476</url>
  </required_header>
  <id_info>
    <org_study_id>ICG-Parathyroid</org_study_id>
    <nct_id>NCT04012476</nct_id>
  </id_info>
  <brief_title>Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy</brief_title>
  <official_title>Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Son Espases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universitat de les Illes Balears</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Son Espases</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intensity of parathyroid fluorescence that occurs after intravenous injection of
      indocyanine green during the performance of a total thyroidectomy correlates with
      postoperative parathyroid function and could be used as a diagnostic marker of postoperative
      hypoparathyroidism and hypocalcemia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of the study is to compare the intensity of parathyroid fluorescence among
      patients who present post-thyroidectomy hypocalcemia with that of patients who do not have
      it. Therefore, the following points will be studied:

        -  To study the correlation between parathyroid vascularization (intraoperative
           fluorescence intensity) and postoperative glandular function (serum calcium and
           parathormone levels).

        -  To compare the surgeon's subjective assessment of parathyroid fluorescence in the groups
           of patients with and without postoperative hypocalcemia.

        -  To compare the objective assessment of parathyroid fluorescence, by using specific
           computer software developed ad hoc, in the groups of patients with and without
           postoperative hypocalcemia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group: patients undergoing total thyroidectomy with intraoperative infusion of intravenous indocyanine green A prospective unicentric and open clinical trial in which the fluorescence intensity of the parathyroid glands after indocyanine administration will be compared between two groups of patients: those with post-thyroidectomy hypocalcemia and patients who do not present it.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Calcemia</measure>
    <time_frame>Day 1 after surgery</time_frame>
    <description>Serum calcium level at 24 hours postoperatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective parathyroid fluorescence</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured on a subjective analogue scale (0: no fluorescence, 1: hypofluorescence or heterogeneous fluorescence, 2: homogeneous hyperfluorescence).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Objective parathyroid fluorescence</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured by specific computer software developed ad hoc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient's age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sex</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient's gender</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Baseline</time_frame>
    <description>Patient's BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery date</measure>
    <time_frame>Baseline</time_frame>
    <description>Day when surgery takes place</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative diagnosis</measure>
    <time_frame>Baseline</time_frame>
    <description>Thyroid pathology indicating total thyroidectomy (thyroid carcinoma, atypical of uncertain significance, goiter or lymphocytic thyroiditis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>Preoperative blood test</time_frame>
    <description>Preoperative vitamin D level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTH preop</measure>
    <time_frame>Immediately before surgery</time_frame>
    <description>Preoperative PTH level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTH 10 min</measure>
    <time_frame>10 minutes post-thyroidectomy</time_frame>
    <description>PTH levels 10 minutes post-thyroidectomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery</measure>
    <time_frame>Inmediately after surgery</time_frame>
    <description>Scope of surgery: total thyroidectomy (TT), TT with central neck dissection, or TT with functional lateral neck dissection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time</measure>
    <time_frame>Inmediately after surgery</time_frame>
    <description>Duration of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parathyroid glands</measure>
    <time_frame>During surgery</time_frame>
    <description>Number of parathyroid glands located during surgery,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parathyroid gland location</measure>
    <time_frame>During surgery</time_frame>
    <description>Location of the parathyroid glands (superior right, inf-right, sup-left, inf-left).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathologic result</measure>
    <time_frame>during the first month after surgery</time_frame>
    <description>Outcome of thyroid pathology (papillary carcinoma, nodular hyperplasia or lymphocytic thyroiditis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thyroid weight</measure>
    <time_frame>during the first month after surgery</time_frame>
    <description>Thyroid weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PG in piece</measure>
    <time_frame>during the first month after surgery</time_frame>
    <description>Presence of parathyroid glands in the surgical piece and number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stay</measure>
    <time_frame>During the first month after surgery</time_frame>
    <description>Number of days of postoperative hospital stay until the day of hospital discharge, measured as full days of 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drain</measure>
    <time_frame>Inmediately after surgery</time_frame>
    <description>Presence and number of surgical drainages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PTH day 1</measure>
    <time_frame>Day 1 after surgery</time_frame>
    <description>PTH levels in the postoperative follow-up,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>During the first month after surgery</time_frame>
    <description>Emergence of postoperative complications.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypocalcemia</condition>
  <condition>Total Thyroidectomy</condition>
  <condition>Hypoparathyroidism Postprocedural</condition>
  <arm_group>
    <arm_group_label>ICG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing total thyroidectomy with visualization of the parathyroid glands under infrared light after intraoperative intravenous injection of 5 mg of indocyanine green</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine Green</intervention_name>
    <description>Administration of 5 mg of intravenous indocyanine green after total thyroidectomy for measurement of parathyroid fluorescence under infrared light</description>
    <arm_group_label>ICG</arm_group_label>
    <other_name>ICG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are going to undergo total thyroidectomy, with or without cervical lymph
             node dissection.

          -  Visualization of 2 or more parathyroid glands during the surgical act.

          -  Normal renal and hepatic functions.

          -  Absence of a history of hypersensitivity reactions to iodine or indocyanine green.

          -  Able to understand the nature and protocol of the study and its procedures

          -  Willingness to participate with the subsequent signing of informed consent.

        Exclusion Criteria:

          -  Age &lt;18 years

          -  Hepatic or renal insufficiency

          -  Hypersensitivity to iodine or to indocyanine green.

          -  Pregnancy or lactation

          -  Inability to understand the nature and procedures of the study.

          -  Patients with known preoperative hyperparathyroidism.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jaime Bonnín Pascual, MD</last_name>
    <phone>871205959</phone>
    <email>jaime.bonnin@ssib.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitari Son Espases</name>
      <address>
        <city>Palma De Mallorca</city>
        <state>Illes Balears</state>
        <zip>07120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Bonnín Pascual, MD</last_name>
      <phone>871205959</phone>
      <email>jaime.bonnin@ssib.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Vidal Fortuny J, Belfontali V, Sadowski SM, Karenovics W, Guigard S, Triponez F. Parathyroid gland angiography with indocyanine green fluorescence to predict parathyroid function after thyroid surgery. Br J Surg. 2016 Apr;103(5):537-43. doi: 10.1002/bjs.10101. Epub 2016 Feb 11.</citation>
    <PMID>26864909</PMID>
  </reference>
  <reference>
    <citation>Vidal Fortuny J, Sadowski SM, Belfontali V, Guigard S, Poncet A, Ris F, Karenovics W, Triponez F. Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery. Br J Surg. 2018 Mar;105(4):350-357. doi: 10.1002/bjs.10783. Epub 2018 Feb 6.</citation>
    <PMID>29405252</PMID>
  </reference>
  <reference>
    <citation>Lang BH, Wong CK, Hung HT, Wong KP, Mak KL, Au KB. Indocyanine green fluorescence angiography for quantitative evaluation of in situ parathyroid gland perfusion and function after total thyroidectomy. Surgery. 2017 Jan;161(1):87-95. doi: 10.1016/j.surg.2016.03.037. Epub 2016 Nov 10.</citation>
    <PMID>27839936</PMID>
  </reference>
  <reference>
    <citation>Zaidi N, Bucak E, Yazici P, Soundararajan S, Okoh A, Yigitbas H, Dural C, Berber E. The feasibility of indocyanine green fluorescence imaging for identifying and assessing the perfusion of parathyroid glands during total thyroidectomy. J Surg Oncol. 2016 Jun;113(7):775-8. doi: 10.1002/jso.24237. Epub 2016 Apr 4.</citation>
    <PMID>27041628</PMID>
  </reference>
  <reference>
    <citation>Gálvez-Pastor S, Torregrosa NM, Ríos A, Febrero B, González-Costea R, García-López MA, Balsalobre MD, Pastor-Pérez P, Moreno P, Vázquez-Rojas JL, Rodríguez JM. Prediction of hypocalcemia after total thyroidectomy using indocyanine green angiography of parathyroid glands: A simple quantitative scoring system. Am J Surg. 2019 Nov;218(5):993-999. doi: 10.1016/j.amjsurg.2018.12.074. Epub 2019 Jan 4.</citation>
    <PMID>30665612</PMID>
  </reference>
  <reference>
    <citation>Rudin AV, McKenzie TJ, Thompson GB, Farley DR, Lyden ML. Evaluation of Parathyroid Glands with Indocyanine Green Fluorescence Angiography After Thyroidectomy. World J Surg. 2019 Jun;43(6):1538-1543. doi: 10.1007/s00268-019-04909-z.</citation>
    <PMID>30659346</PMID>
  </reference>
  <results_reference>
    <citation>Bonnin-Pascual J, Álvarez-Segurado C, Jiménez-Segovia M, Bianchi A, Bonnin-Pascual F, Molina-Romero FX, González-Argente FX. Contributions of fluorescence to endocrine surgery. Cir Esp. 2018 Nov;96(9):529-536. doi: 10.1016/j.ciresp.2018.09.005. Epub 2018 Oct 14. English, Spanish.</citation>
    <PMID>30327136</PMID>
  </results_reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>June 28, 2019</study_first_submitted>
  <study_first_submitted_qc>July 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2019</study_first_posted>
  <last_update_submitted>July 7, 2019</last_update_submitted>
  <last_update_submitted_qc>July 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypocalcemia post-thyroidectomy</keyword>
  <keyword>Indocyanine green</keyword>
  <keyword>Fluorescence guided surgery</keyword>
  <keyword>Parathyroid fluorescence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypocalcemia</mesh_term>
    <mesh_term>Hypoparathyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

